Rigel Pharma Insider Trades: CEO & Execs Sell 18K Shares Amid Market Shifts
Insider trades at Rigel Pharma reveal portfolio moves, not panic—executives’ actions amid a dip in shares, yet confidence stays high as Q3 2026 clinical data approaches.
4 minutes to read